Severe asthma represents a burden for both patients and society. Modulation of the underlying inflammation has been the basis of the treatment, becoming much more efficient in the biologics era, introducing precision medicine. However, representing the complexity of underlying immunopathology, we have an increasing number of immunomodulators, from inhaled corticosteroid use and allergen immunotherapy to biologics and macrolides, with many more on their way. It is becoming challenging for fellow physicians to recognise the right endotype and choose the most appropriate immunomodulatory treatment. The challenge is further increasing for fellow physicians who have difficulties referring to a specialist severe asthma clinic.
Participants will update their knowledge on understanding the basis of the immunopathology of severe asthma.
- Lectures and case-based presentations
- Introduction by the Chairs – Apostolos Bossios (Stockholm, Sweden), Lena Uller (Lund, Sweden) – 2 minutes
- Immunopathology overview of severe asthma – Apostolos Bossios (Stockholm, Sweden) – 15 minutes
- Allergen immunotherapy in patients with severe asthma, where to consider it? – Walter Canonica (Milan, Italy) – 15 minutes
- Choosing and monitoring the right immunomodulatory therapy for asthma – Celeste Porsbjerg (Copenhagen, Denmark) – 15 minutes
- Q&A – 15 minutes
Following the webinar, participants will be able to:
- Recognise and identify the correct phenotype and the linked endotype in patients with severe asthma.
- Choose and monitor the most appropriate immunomodulatory treatment for their patients.
Treatments that will be discussed are allergen immunotherapy, biologics, and other immune modulators as macrolides. Finally, strategies at follow up treatment and monitor its effects will be also reviewed.
An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.
What is a webinar?
The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.
This webinar comprises of a 45-minute lecture followed by a 15-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls.
All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.
More information will be communicated in due course.
- Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact email@example.com.
- Check Central European Summer Time.
- To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
- Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.
Diseases / methods
- Airway diseases
- Allied respiratory professionals